GB202215990D0 - Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia - Google Patents

Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia

Info

Publication number
GB202215990D0
GB202215990D0 GBGB2215990.9A GB202215990A GB202215990D0 GB 202215990 D0 GB202215990 D0 GB 202215990D0 GB 202215990 A GB202215990 A GB 202215990A GB 202215990 D0 GB202215990 D0 GB 202215990D0
Authority
GB
United Kingdom
Prior art keywords
hypercholesterolemia
treatment
nucleic acid
acid editing
guide oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2215990.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ProQR Therapeutics II BV
Original Assignee
ProQR Therapeutics II BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ProQR Therapeutics II BV filed Critical ProQR Therapeutics II BV
Priority to GBGB2215990.9A priority Critical patent/GB202215990D0/en
Publication of GB202215990D0 publication Critical patent/GB202215990D0/en
Priority to PCT/EP2023/053503 priority patent/WO2023152371A1/en
Ceased legal-status Critical Current

Links

GBGB2215990.9A 2022-02-14 2022-10-28 Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia Ceased GB202215990D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2215990.9A GB202215990D0 (en) 2022-10-28 2022-10-28 Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia
PCT/EP2023/053503 WO2023152371A1 (en) 2022-02-14 2023-02-13 Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2215990.9A GB202215990D0 (en) 2022-10-28 2022-10-28 Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia

Publications (1)

Publication Number Publication Date
GB202215990D0 true GB202215990D0 (en) 2022-12-14

Family

ID=84839276

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2215990.9A Ceased GB202215990D0 (en) 2022-02-14 2022-10-28 Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia

Country Status (1)

Country Link
GB (1) GB202215990D0 (en)

Similar Documents

Publication Publication Date Title
IL287643A (en) Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapy
EP3466423A3 (en) Treatment of cancer with tor kinase inhibitors
IL288707A (en) Methods of using rad51 inhibitors for treatment of pancreatic cancer
IL304275A (en) Methods for treating cancer
GB202216943D0 (en) Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia
GB202215990D0 (en) Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia
GB202201902D0 (en) Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia
GB202101848D0 (en) Guide oligonucleotides for nucleic acid editing in the treatment of hypercholesterolemia
IL290770A (en) Compounds and methods for treating oxalate-related diseases
EP4138900A4 (en) Method for treating cervical cancer
IL306119A (en) Gene therapy for treating beta-hemoglobinopathies
IL272194A (en) Multispecific antibodies for use in treating diseases
GB202216877D0 (en) Nucleic acid editing in the treatment of liver disease
GB201918313D0 (en) Cells for treating cancer
SG10201906239RA (en) Compositions and methods for inhibition of rna editing for treatment of cancer
GB202214347D0 (en) Chemically modified oligonucleotides for adar-mediated RNA editing
EP4110406A4 (en) Methods for treating gain-of-function disorders combining gene editing and gene therapy
KR102398032B9 (en) 5'- 5'-nucleotidas variants for treatment cancer
GB202318087D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202304438D0 (en) Antisense oligonucleotides for the treatment of liver disease
GB202306060D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
GB202217580D0 (en) Antisense oligonucleotides for the treatment of hereditary hfe-hemochromatosis
IL311281A (en) Multispecific antibodies for use in treating diseases
IL305780A (en) Methods for the treatment of cancer
GB202308670D0 (en) New formulations for treating opioid use disorder

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)